Kategorien
Mein Mercateo
Anmelden / Registrieren
Warenkorb
 
 

Advances in Down Syndrome Research


Menge:  Stück  
Produktinformationen
cover
cover
Artikel-Nr.:
     5667A-9783211407813
Hersteller:
     Springer Verlag
Herst.-Nr.:
     9783211407813
EAN/GTIN:
     9783211407813
Suchbegriffe:
Medizinbücher
Medizinbücher - englischsprachig
medizinbücher - englischsprachig
"Advances in Down Syndrome Research" represents updated research in several areas of Down Syndrome (DS). A new promising animal model of DS is reported and this opens new opportunities to study pathomechanisms and pharmacological approaches as it is more than difficult to carry out studies in humans and the clinical features are highly variable. In terms of biology, cell cycle and stem cell studies and in terms of biochemistry, relevance of studies on a specific protein kinase, channels, transporters, superoxide dismutase, antioxidant system, chromosome assembly factor and other important biological structures are provided. And again, the gene dosage hypothesis is addressed and although the vast majority of chromosome 21 gene products is unchanged in fetal DS brain, a few specific chromosome 21 encoded structures including transcription factors are indeed overexpressed although findings in fetal DS are different from those in adult DS brain when Alzheimer-like neuropathology supervenes.
Weitere Informationen:
Author:
Gert Lubec
Verlag:
Springer Wien
Sprache:
eng
Weitere Suchbegriffe: Down-Syndrom - Trisomie 21, alzheimer'sdisease; Chromosom; Downsyndrome; Emotion; Microarray; Regulation; Syndrom; biologicalfunctions; Chromosome21; transcription, Alzheimer's disease, Chromosom, Down syndrome, Emotion, Microarray, Regulation, Syndrom, biological functions, chromosome 21
Die Konditionen im Überblick1
Lieferzeit
Lagerstand
Preis
€ 149,99*
Konditionen selbst auswählen
Artikel empfehlenArtikel merken
* Preise mit Sternchen sind Nettopreise zzgl. gesetzlich gültiger MwSt.
UVP bedeutet „Unverbindliche Preisempfehlung“
Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.